Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,309 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06858748Recruiting
Mucus in airways: asthma, COPD, and chronic cough study
This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.
Vancouver, British ColumbiaAges 18 years+ - NCT06861673Recruiting
Combined PVI and LAAC study
This study is testing if a procedure that combines two treatments—pulmonary vein isolation for atrial fibrillation and left atrial appendage closure to lower stroke risk—can be done safely together. It's for people who need both treatments.
Hamburg, Free and Hanseatic City of HamburgAges Any age - NCT06865118Recruiting
Home management of heart issues in scleroderma
This study tests whether people with systemic sclerosis (scleroderma) and pulmonary arterial hypertension (PAH) can safely monitor their heart health at home using a smartphone or other internet-connected device. If you have PAH and are comfortable using technology, this trial may help make care more convenient.
OsloAges 18 years+ - NCT06878261RecruitingPhase 3
Tezepelumab for moderate to very severe COPD
This study tests a new medication called tezepelumab (given as a shot) to see if it can reduce COPD flare-ups in people with moderate to very severe COPD who have had recent flare-ups despite using inhalers. It may be an option for those with higher levels of eosinophils (a type of white blood cell) in their blood.
Cullman, AlabamaAges 40–80 - NCT06883305RecruitingPhase 3
Testing tezepelumab for moderate to severe COPD
This trial tests tezepelumab, an injected medication, for people with moderate to very severe COPD who still have flare-ups despite using standard inhalers. It may help reduce flare-ups and improve breathing for those with higher eosinophil levels.
Foley, AlabamaAges 40–80 - NCT06889467Recruiting
Testing leftover fluid from lymph node biopsies to find lung cancer
This trial is for people who are scheduled for a lung cancer biopsy (EBUS-TBNA) because doctors suspect non-small cell lung cancer (NSCLC) has spread to lymph nodes. It will test leftover fluid from the biopsy to see if it improves cancer detection. If your biopsy is negative but you still need surgery to remove lymph nodes, you can help us learn more about this new test.
AshkelonAges 18 years+ - NCT06886516RecruitingEarly Phase 1
Blood thinner study for cancer patients with low platelets
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
Boston, MassachusettsAges 18 years+ - NCT06887140Recruiting
Heart-lung function test in sepsis patients
This study uses an ultrasound of the heart (echocardiogram) to check how well the right side of your heart is working with your lungs during sepsis. The goal is to see if this measurement can help doctors predict how patients will recover.
Ho Chi Minh CityAges 18 years+ - NCT06888557Recruiting
Smartphone help for COPD: improve quality of life
This trial tests a smartphone-based program to help people with COPD manage their condition and feel better. You will use WhatsApp or WeChat to get support and track your activity.
Hong Kong, Hong KongAges 40 years+ - NCT06890767Recruiting
Wearable monitoring for COPD patients in the hospital
This study tests whether using a wearable device (like a sensor or smartwatch) can help doctors check on COPD patients while they are in the hospital for a bad flare-up. The goal is to see if remote monitoring can make care better and help you get home sooner.
Genk, LimburgAges 18 years+ - NCT06894095Recruiting
Heart and blood vessel imaging study for adults with coronary CT
This study collects heart and blood vessel images from people who have already had a coronary CT scan. It aims to learn more about heart health and may help future patients.
Nanjing, JiangsuAges 18 years+ - NCT06899815RecruitingPhase 1
Early safety study of F230 tablets in healthy volunteers
This trial tests a new medicine, F230, in healthy people for the first time. The goal is to check how safe it is and how the body handles it. You might consider this if you are a healthy adult looking to help advance medical research.
Hubei, WuhanAges 18–45 - NCT06900062Recruiting
Bronchiectasis Research Study at Shanghai Hospital
This study looks at the genes and health data of people with bronchiectasis to better understand the disease. It may help find new ways to treat or manage your condition.
Guiyang, GuizhouAges 18–85 - NCT06905522RecruitingPhase 3
Tuberculosis treatment trial for new patients
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
BeijingAges 18–65 - NCT06906926Recruiting
Studying the Harmony heart valve for long-term safety
This study is following people who get the Harmony valve to see how well it works over time. The valve helps blood flow from the heart to the lungs in people with certain heart conditions.
CopenhagenAges Any age - NCT06909409Recruiting
Vitamin D and lung immune cells in lung fibrosis
This study looks at how vitamin D affects immune cells in the lungs of people with a lung scarring condition called idiopathic pulmonary fibrosis (IPF) or other similar lung diseases. It tests if vitamin D levels are linked to how these cells work.
Aarhus NAges 18 years+ - NCT06915961Recruiting
HE4 Protein and Lung Function in Cystic Fibrosis
This study looks at a protein in the blood (HE4) and how it relates to lung function in children with cystic fibrosis. It also tests a quality improvement plan to help manage CF. The goal is to find better ways to track and treat the disease.
Cairo, AbbasiaAges 6 years+ - NCT06924398RecruitingPhase 2
Post-surgery targeted therapy for remaining lung nodules in EGFR-mutant NSCLC
This trial tests whether a targeted therapy pill (EGFR-TKI) can control small spots in the other lung after surgery for early-stage lung cancer. It's for people whose cancer has a specific EGFR gene change and who still have suspicious spots in the opposite lung after one side is removed.
Guangzhou, GuangdongAges 18–75 - NCT06925295RecruitingPhase 2
Xenon MRI to guide radiation for lung cancer
This trial tests whether a special MRI that uses xenon gas can help doctors better plan radiation therapy for lung cancer. You may join if you are scheduled for stereotactic body radiation therapy for your lung cancer.
Iowa City, IowaAges 18–80 - NCT06926881Recruiting
Home treatment with oscillatory lung expansion for bronchiectasis
This trial tests a home-use device called BiWaze Clear, which helps clear mucus from your lungs. It is for people with bronchiectasis (including those with cystic fibrosis) who have had recent lung infections and can use the device at home.
New Haven, ConnecticutAges 5 years+ - NCT06934499Recruiting
Tunisian lung cancer study for adults
This study looks at treatments and care for people living in Tunisia who have been diagnosed with lung cancer. It may help researchers learn more about options available for lung cancer patients.
AryanahAges 18 years+ - NCT06933758Recruiting
Temple Health Chest Lung Screening Study
This study looks at how a hospital program can help people who are at risk for lung cancer get the proper screening and follow-up care. You may be eligible if you are a Temple patient and have had a low-dose CT scan for lung cancer screening.
Philadelphia, PennsylvaniaAges 50–80 - NCT06937905RecruitingPhase 3
Tarlatamab vs chemo for advanced NEC after one prior treatment
This trial tests a new immunotherapy drug called tarlatamab, which targets the DLL3 protein on cancer cells, versus standard chemotherapy for people with advanced neuroendocrine carcinoma (NEC). You may qualify if your NEC has gotten worse after just one prior platinum chemotherapy and your tumor has DLL3.
AngersAges 18 years+ - NCT06940427RecruitingPhase 2
Testing a new PET scan for lung scarring
This trial is testing a new type of PET scan (FAPI PET) to help doctors see if lung scarring (fibrosis) is getting worse or getting better. It may help decide if a treatment change is needed.
Madison, WisconsinAges 18 years+
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,309 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.